Surgical management of bisphosphonate induced osteonecrosis of the jaws
- PMID: 20015614
- DOI: 10.1016/j.ijom.2009.11.014
Surgical management of bisphosphonate induced osteonecrosis of the jaws
Abstract
Recent literature contains numerous articles on osteonecrosis of the jaws (ONJ) associated with bisphosphonate treatment (BPT), with most advocating a conservative approach to management. A prospective study was designed to review the surgical management of cases of ONJ that did not respond to conservative management. Forty patients, referred with ONJ that did not respond to conservative management, were treated surgically and followed up for 6 months to 4 years. Four patients were taking i.v. BPT as part of their bone cancer management and 16 were taking oral BPT for osteoporosis. The surgical management of ONJ involved antibiotic therapy, surgical debridement of all necrotic bone and tension-free primary closure. All 40 cases healed uneventfully with no wound breakdown during follow-up. Most of the literature supports the conservative management of ONJ, but the condition leaves the patient debilitated. Many cases do not respond to conservative management and the infection and bone destruction is progressive. The conservative management of ONJ is to be supported, but this prospective study has shown that those cases that do not respond may be managed surgically. It should be recognized that while the results of this paper are encouraging, some cases will be resistant to all treatments.
Similar articles
-
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.J Rheumatol. 2009 Dec;36(12):2780-7. doi: 10.3899/jrheum.090455. Epub 2009 Nov 2. J Rheumatol. 2009. PMID: 19884275
-
[Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er:YAG (2940 nm) laser. Discussion of 17 clinical cases].Rev Belge Med Dent (1984). 2009;64(2):87-95. Rev Belge Med Dent (1984). 2009. PMID: 19681350 French.
-
Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.Br Dent J. 2007 Jul 28;203(2):91-2. doi: 10.1038/bdj.2007.635. Br Dent J. 2007. PMID: 17660779
-
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.Clin Ther. 2007 Aug;29(8):1548-58. doi: 10.1016/j.clinthera.2007.08.008. Clin Ther. 2007. PMID: 17919538 Review.
-
[Bisphosphonates and osteonecrosis of the jaws].Clin Calcium. 2007 Feb;17(2):241-8. Clin Calcium. 2007. PMID: 17272882 Review. Japanese.
Cited by
-
Mandibulectomy Reconstruction with Pectoralis Major Island Flap Associated with Primary Reconstruction Plate for Mandibular Medication-Related Osteonecrosis.Curr Health Sci J. 2021 Jan-Mar;47(1):117-122. doi: 10.12865/CHSJ.47.01.19. Epub 2021 Mar 31. Curr Health Sci J. 2021. PMID: 34211758 Free PMC article.
-
[Bisphosphonate-associated osteonecrosis of the jaw].Schmerz. 2015 Apr;29(2):171-8. doi: 10.1007/s00482-014-1499-y. Schmerz. 2015. PMID: 25860198 Review. German.
-
Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case series.Clin Oral Investig. 2015 Jul;19(6):1329-38. doi: 10.1007/s00784-014-1384-1. Epub 2014 Dec 17. Clin Oral Investig. 2015. PMID: 25511385
-
Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.Clin Oral Investig. 2019 Aug;23(8):3203-3211. doi: 10.1007/s00784-018-2743-0. Epub 2018 Nov 8. Clin Oral Investig. 2019. PMID: 30406491 Review.
-
Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro.Clin Oral Investig. 2015 Sep;19(7):1625-33. doi: 10.1007/s00784-014-1394-z. Epub 2015 Jan 16. Clin Oral Investig. 2015. PMID: 25589370
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical